Cost Saving Opportunities in NSCLC Therapy by Optimized Diagnostics.

about

Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features.Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.PD-L1 immunohistochemistry for non-small cell lung carcinoma: which strategy should be adopted?

P2860

Q41670942-BB1799CD-D992-48A5-9E10-0A6DF5392DAA Q44136116-766D9EE9-21A8-440E-8B56-51FB1F7D9BE6 Q48620065-389014BA-6A50-417B-A861-2AD859E29BAA

P2860

Cost Saving Opportunities in NSCLC Therapy by Optimized Diagnostics.

Item

http://www.wikidata.org/entity/Q38684398

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Cost Saving Opportunities in NSCLC Therapy by Optimized Diagnostics.

@en

type

Item

label

Cost Saving Opportunities in NSCLC Therapy by Optimized Diagnostics.

@en

prefLabel

Cost Saving Opportunities in NSCLC Therapy by Optimized Diagnostics.

@en

P1476

Cost Saving Opportunities in NSCLC Therapy by Optimized Diagnostics.

@en

P2093

Guus Simons

http://www.w3.org/2001/XMLSchema#string

Ilija Nenadić

http://www.w3.org/2001/XMLSchema#string

Jeanine Staber

http://www.w3.org/2001/XMLSchema#string

Michael Brockmann

http://www.w3.org/2001/XMLSchema#string

Oliver Schildgen

http://www.w3.org/2001/XMLSchema#string

Susanne Dreier

http://www.w3.org/2001/XMLSchema#string

Verena Schildgen

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular testing in lung cancer in the era of precision medicine

Role of molecular studies in the diagnosis of lung adenocarcinoma

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

Improving HIV coreceptor usage prediction in the clinic using hints from next-generation sequencing data.

Lung cancer: current diagnosis and treatment

Companion diagnostics for targeted cancer drugs - clinical and regulatory aspects

Geno2pheno[454]: a Web server for the prediction of HIV-1 coreceptor usage from next-generation sequencing data.

An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data.

P31

scholarly article

P356

10.3390/CANCERS9070088

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28696381

http://www.w3.org/2001/XMLSchema#string

P932

5532624

http://www.w3.org/2001/XMLSchema#string

Cost Saving Opportunities in NSCLC Therapy by Optimized Diagnostics.

about

P2860

P2860

Cost Saving Opportunities in NSCLC Therapy by Optimized Diagnostics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P932